Sky's dividend rose 21.4% as EBITDA fell 25.7% to $60.7m

With pre-lease FCF of $7.5m (down from $23.7m), the payout ratio reached 156.3% versus the supplied historical mean of 33.5% (range 0%–63.3%) — classified as an unprecedented high in Annolyse's historical baseline. Revenue declined 2.0% to $384.8m, the first contraction against a 4-period mean of +4.4%.

OCF was essentially flat at $62.7m, lifting cash conversion to 103.3% from 77.0%. Annolyse's baseline records a working-capital release of -$874.7m versus a 3-period mean of -$17.8m, although flat OCF year-on-year implies the underlying operating working-capital flow was less extreme than that delta suggests. Cash fell to $27.8m from $47.4m, and total assets at $625.9m sit below the recent $667.4m–$748.7m range.

At 156.3% of pre-lease FCF, the 8.5cps interim is not self-funded from this half's cash. Management states the dividend is "protected from one-offs", but the cash balance dropped $19.6m, so this period's distribution capacity is being supported from reserves rather than earned cash.

The operating reset is broad. EBITDA margin compressed from roughly 20.8% to 15.8%, ROE moved to -0.5% from +6.4%, and revenue declined for the first time in the supplied 4-period baseline. Management attributes this to migration prioritisation displacing revenue-generating projects and an H1-weighted programming cost shape.

The loss is operating, not tax-distorted. PBT fell 106.0% and NPAT fell 106.8%, a gap of just 0.8 percentage points, with the effective tax rate steady at 28.0% versus 28.4% prior. The swing to a loss reflects gross margin and cost dynamics, not below-the-line items.

HY24 contributed 51.2% of FY24 revenue and 53.4% of FY24 EBITDA, so H2-weighted earnings are the normal pattern, but the bar is now higher: matching FY24 EBITDA of $153m would require an H2 EBITDA of roughly $92m, well ahead of the $71.3m HY24 implied H2 contribution.

No specific FY25 EBITDA target is supplied in this release. The forward question is whether H2 cash generation can fund both the residual interim dividend bridge and any final dividend at FY24's $0.175 floor without further drawing on cash reserves.

The release explicitly acknowledges "one-off items (largely non-cash or expected to be cash neutral) that mask a more positive underlying result", but the $21m EBITDA decline is the cash-relevant figure for FCF and dividend coverage, regardless of whether reported earnings are characterised as understated. Capex held at 10.6% of revenue, in line with the 10.55% prior, so FCF compression is EBITDA-driven rather than capex creep.

Pre-lease FCF of $7.5m sits below Annolyse's historical range ($16.0m–$87.1m, mean $45.2m). The FCF/NPAT ratio of -383.0% is not meaningful given the loss, but the FCF level itself is. With distributions declared above this half's FCF and cash down $19.6m, current capital return is balance-sheet-funded for this period — durable only if H2 cash recovery is delivered.

This briefing cannot assess the dollar quantification of "underlying" results, the specific composition of one-off items, or any unstated FY25 EBITDA range referenced as existing guidance.